Envision, A Phase 3 Study To Evaluate Efficacy And Safety Of Givosiran, An Investigational Rnai Therapeutic Targeting Aminolevulinic Acid Synthase 1, In Acute Hepatic Porphyria Patients

JOURNAL OF HEPATOLOGY(2019)

引用 8|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要